SGX523

· SGX Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGX523, covering 2008-07-24 to 2008-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors [Phase 1]